9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
QuantumLeap Healthcare Collaborative
George Washington University
Psyence Australia Pty Ltd
Institut Curie
George Washington University
TNC Nutrición Terapéutica S.L.
Case Comprehensive Cancer Center
HealthPartners Institute
Brigham and Women's Hospital
Bayer
University of Colorado, Denver
Institut Bergonié
SOLTI Breast Cancer Research Group
Proton Collaborative Group
Duke University
Oslo University Hospital
Oslo University Hospital
Exelixis
CytomX Therapeutics
Hoffmann-La Roche
Eisai Inc.
Stony Brook University
Bristol-Myers Squibb
University of Auckland, New Zealand
Bayer
University of Kansas Medical Center
Baylor Breast Care Center
Pfizer
NYU Langone Health
Baylor Breast Care Center
University of California, San Francisco
AstraZeneca
Novartis
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Avera McKennan Hospital & University Health Center
Eli Lilly and Company
AstraZeneca
Masonic Cancer Center, University of Minnesota
Novartis
Novartis
Tampere University Hospital
Amgen
Sinocelltech Ltd.
Puma Biotechnology, Inc.
Nektar Therapeutics
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
The West Clinic, Memphis
SOLTI Breast Cancer Research Group